Product Information
IMATINIB MESYLATE 100 MG TAB is a generic product labeled by Armas Pharmaceuticals Inc., priced at $0.4912 per EA under NDC 72485020290. Its NADAC has been published 203 times since Oct 30, 2019.
The Low Outlier badge above means this manufacturer's average price in the imatinib mesylate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Armas Pharmaceuticals Inc.NDC
72485020290
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
7/17/2024
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA208302On Market Since
3/15/2019
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 100 MG TAB has been published 203 times since Oct 30, 2019, and over the history we have for it it has declined 90.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4912 per EA |
|---|---|
| All-time high | $4.9463 (Feb 12, 2020) |
| All-time low | $0.3890 (May 22, 2024) |
| Median price | $0.8120 |
| Average price | $1.7749 |
| Largest weekly change | -74.1% (Jun 22, 2022) |
| Weeks tracked | 203 |
| Tracking since | Oct 30, 2019 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 100 MG TAB, manufactured by Armas Pharmaceuticals Inc., is $0.4912 per EA (NDC 72485020290), effective Aug 14, 2024.
How has the price of IMATINIB MESYLATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 100 MG TAB has declined 90.1%. It has been tracked across 203 weekly CMS publications since Oct 30, 2019.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 100 MG TAB?
Since Oct 30, 2019, the NADAC for IMATINIB MESYLATE 100 MG TAB has ranged from a low of $0.3890 (May 22, 2024) to a high of $4.9463 (Feb 12, 2020), with a median of $0.8120 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 100 MG TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as IMATINIB MESYLATE 100 MG TAB, but none are currently priced below it.
Who manufactures IMATINIB MESYLATE 100 MG TAB?
IMATINIB MESYLATE 100 MG TAB (NDC 72485020290) is labeled by Armas Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification